Gaetana Capobianco

433 total citations
21 papers, 281 citations indexed

About

Gaetana Capobianco is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Gaetana Capobianco has authored 21 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Gaetana Capobianco's work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Gaetana Capobianco is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Gaetana Capobianco collaborates with scholars based in Italy, Switzerland and India. Gaetana Capobianco's co-authors include Antonio Pinto, Ferdinando Frigeri, Gaetano Corazzelli, Filippo Russo, Manuela Arcamone, Cristina Becchimanzi, Gianpaolo Marcacci, Annarosaria De Chiara, Emanuela Morelli and Rosaria De Filippi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Gaetana Capobianco

21 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gaetana Capobianco Italy	10	198	134	90	68	42	21	281
Manuela Arcamone Italy	8	283 1.4×	191 1.4×	108 1.2×	88 1.3×	37 0.9×	24	357
Marjan Ertault France	9	222 1.1×	88 0.7×	84 0.9×	54 0.8×	51 1.2×	14	306
Hanne Kuitunen Finland	12	270 1.4×	168 1.3×	157 1.7×	92 1.4×	45 1.1×	45	380
Alessandra Cuttica Italy	8	204 1.0×	147 1.1×	80 0.9×	47 0.7×	41 1.0×	10	287
Lucille Baseggio France	4	276 1.4×	137 1.0×	169 1.9×	75 1.1×	39 0.9×	9	315
Jordina Rovira Spain	8	227 1.1×	137 1.0×	89 1.0×	59 0.9×	52 1.2×	9	310
Alessia Castellino Italy	11	279 1.4×	180 1.3×	102 1.1×	143 2.1×	27 0.6×	34	356
Marita Kloess Germany	7	265 1.3×	136 1.0×	121 1.3×	189 2.8×	37 0.9×	12	348
Olga Kolman United States	4	252 1.3×	160 1.2×	153 1.7×	63 0.9×	29 0.7×	7	309
Massimo Federico Italy	12	181 0.9×	186 1.4×	80 0.9×	95 1.4×	26 0.6×	26	377

Countries citing papers authored by Gaetana Capobianco

Since Specialization

Citations

This map shows the geographic impact of Gaetana Capobianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaetana Capobianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaetana Capobianco more than expected).

Fields of papers citing papers by Gaetana Capobianco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaetana Capobianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaetana Capobianco. The network helps show where Gaetana Capobianco may publish in the future.

Co-authorship network of co-authors of Gaetana Capobianco

This figure shows the co-authorship network connecting the top 25 collaborators of Gaetana Capobianco. A scholar is included among the top collaborators of Gaetana Capobianco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaetana Capobianco. Gaetana Capobianco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corazzelli, Gaetano, Annarosa Cuccaro, Emanuela Morelli, et al.. (2024). Long‐term efficacy and safety of dose‐dense and dose‐intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15‐year follow‐up of the ABVD_DD‐DI phase II study. British Journal of Haematology. 205(4). 1383–1388. 1 indexed citations

Galati, Domenico, Serena Zanotta, Gaetano Corazzelli, et al.. (2018). Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma. British Journal of Haematology. 184(4). 594–604. 13 indexed citations

Franco, Renato, Giosuè Scognamiglio, Antonio Luciano, et al.. (2016). PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas. Oncotarget. 7(37). 59158–59172. 13 indexed citations

Filippi, Rosaria De, Stefania Crisci, Domenico Galati, et al.. (2015). The First-in-Class Alkylating Histone-Deacetylase Inhibitor (HDACi) Fusion Molecule Edo-S101 Exerts Potent Preclinical Activity Against Tumor Cells of Hodgkin Lymphoma (HL) Including Bendamustine-Resistant Clones. Blood. 126(23). 2481–2481. 2 indexed citations

Aloj, Luigi, Michela Aurilio, Ferdinando Frigeri, et al.. (2014). Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 41(5). 867–877. 25 indexed citations

Russo, Filippo, Gaetano Corazzelli, Ferdinando Frigeri, et al.. (2014). A phase II study of dose‐dense and dose‐intense ABVD (ABVD_DD‐DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma. British Journal of Haematology. 166(1). 118–129. 5 indexed citations

Filippi, Rosaria De, Fortunato Morabito, Gaetano Corazzelli, et al.. (2012). Use of the cumulative amount of serum-free light chains (sFLC) at diagnosis and PET2 for the early identification of high risk of treatment failure in Hodgkin lymphoma (cHL).. Journal of Clinical Oncology. 30(15_suppl). 8083–8083. 1 indexed citations

Corazzelli, Gaetano, Ferdinando Frigeri, Manuela Arcamone, et al.. (2011). Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy. British Journal of Haematology. 154(5). 579–589. 41 indexed citations

Corazzelli, Gaetano, Ferdinando Frigeri, Manuela Arcamone, et al.. (2011). Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas. European Journal Of Haematology. 87(6). 547–553. 1 indexed citations

10.

Corazzelli, Gaetano, Ferdinando Frigeri, Filippo Russo, et al.. (2011). RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma. British Journal of Haematology. 156(2). 234–244. 57 indexed citations

11.

Corazzelli, Gaetano, Ferdinando Frigeri, Gianpaolo Marcacci, et al.. (2010). Gemcitabine, Ifosfamide, Oxaliplatin (GIFOX) as First-Line Treatment In High-Risk Peripheral T-Cell/NK Lymphomas: A Phase II Trial.. Blood. 116(21). 2829–2829. 11 indexed citations

12.

Corazzelli, Gaetano, Gaetana Capobianco, Manuela Arcamone, et al.. (2009). Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma. Cancer Chemotherapy and Pharmacology. 64(5). 907–916. 58 indexed citations

13.

Russo, Filippo, Gaetano Corazzelli, Secondo Lastoria, et al.. (2009). Dose-Dense(dd) ABVD and Dose-Dense/Dose-Intense(dd-di) ABVD in Newly Diagnosed Patients (pts), Intermediate- and Advanced-Stage with Classical Hodgkin's Lymphoma (cHL): Final Results.. Blood. 114(22). 715–715. 2 indexed citations

14.

Filippi, Rosaria De, Filippo Russo, Stefania Crisci, et al.. (2009). Abnormally Elevated Levels of Serum Free-Immunoglobulin Light Chains Are Frequently Found in Classic Hodgkin Lymphoma (cHL) and Predict Outcome of Patients with Early Stage Disease.. Blood. 114(22). 267–267. 9 indexed citations

15.

Corazzelli, Gaetano, Gaetana Capobianco, Manuela Arcamone, et al.. (2008). Rituximab Plus Gemcitabine, Ifosfamide, Oxaliplatin (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Hodgkin Lymphoma. Blood. 112(11). 2601–2601. 2 indexed citations

16.

Capobianco, Gaetana, et al.. (2007). Cardiotoxicity and Treatment Efficacy of Not Pegilated Liposomal Doxorubicin in Haematological Malignancies: Our Experience.. Blood. 110(11). 4836–4836. 1 indexed citations

17.

Corazzelli, Gaetano, Gaetana Capobianco, Filippo Russo, et al.. (2005). Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.. PubMed. 90(3). ECR14–ECR14. 19 indexed citations

18.

Corazzelli, Gaetano, et al.. (2005). Gemcitabine, Ifosfamide, Oxaliplatin and Rituximab (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma: Results of a Pilot Study.. Blood. 106(11). 940–940. 3 indexed citations

19.

Russo, Filippo, Gaetano Corazzelli, Ferdinando Frigeri, et al.. (2005). The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin’s Lymphoma.. Blood. 106(11). 2671–2671. 1 indexed citations

20.

D’Amico, Maria Rosaria, et al.. (2002). A Case of Congenital Dyserythropoietic Anemia Type II, Gilbert's Syndrome and Malleolar Trophic Ulcers. Hematology. 7(3). 197–199. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact